Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZETA is an Austrian private company that provides end-to-end engineering, automation, fabrication, digitalization, and qualification services for the biotech and pharmaceutical industries. Rather than developing its own therapeutic pipeline, the company supports customers across the full lifecycle of biopharma manufacturing, from process design and pilot-scale development to GMP production, facility build-out, and operations support. ZETA focuses especially on aseptic liquid processing and biomanufacturing systems, including equipment and integrated solutions for large molecules, cell and gene therapy, mRNA, vaccines, and selected small-molecule applications. The company also offers proprietary products such as magnetic mixing technology, process vessels, and inline conditioning systems, alongside EPCMV delivery and Pharma 4.0-oriented automation. It operates internationally with headquarters in Lieboch, Austria and a growing North American presence through ZETA USA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZETA.